FAVCX | VIVIX | FAVCX / VIVIX | |
Total Expense Ratio | 1.70 | 0.04 | 4,250% |
Annual Report Gross Expense Ratio | 1.70 | 0.04 | 4,250% |
Fund Existence | 24 years | 27 years | - |
Gain YTD | 6.380 | 6.730 | 95% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 208M | 195B | 0% |
Annual Yield % from dividends | 0.65 | 2.19 | 30% |
Returns for 1 year | 4.37 | 9.75 | 45% |
Returns for 3 years | 15.53 | 34.32 | 45% |
Returns for 5 years | 52.64 | 74.87 | 70% |
Returns for 10 years | 55.27 | 116.26 | 48% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NDVRX | 16.44 | 0.12 | +0.74% |
MFS New Discovery Value R1 | |||
JVMSX | 29.24 | 0.18 | +0.62% |
JHancock Disciplined Value Mid Cap R2 | |||
MLNCX | 25.28 | 0.15 | +0.60% |
Morgan Stanley Instl Glbl Concntr C | |||
PFPGX | 28.99 | 0.16 | +0.55% |
Parnassus Growth Equity Institutional | |||
JUSSX | 18.13 | 0.08 | +0.44% |
JPMorgan US Small Company L |